Fundraising Fox
/Companies
Sign in

Chimerix

Durham, US · Founded 2003 · 3,654 employees on LinkedIn · 7 known investors

Find your way into Chimerix

Sign up to see every warm intro you have to Chimerix

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Chimerix team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Chimerix is a biopharmaceutical company developing therapies for rare diseases and cancers, with a focus on advancing treatments through biomarker-driven approaches and precision medicine.

BiotechHealthtechMedical Devices

Founders & leadership

MS
Mike ShermanChief Executive Officer and President
WG
W. Garrett NicholsChief Medical Officer
MA
Michael A. AlrutzExecutive
RL
Randall LanierChief Science Officer
RW
Roy W. WareChief Manufacturing and Technology Officer
HK
Heather Knight-TrentVice President of Regulatory Affairs
ONOdin Naderer
Odin NadererExecutiveExecutive Officer at Chimerix NASDAQ: CMRX www.chimerix.com
GP
George PainterFounder
KH
Karl HostetlerFounder

Board

RC
Ronald C. Renaud, JrBoard director
MJ
Martha J. DemskiBoard director
JM
James M. DalyBoard director

Investors · 7

Alta Partnerslisted by Alta PartnersJackson · $1M – $12M

How we know: Alta Partners's portfolio page · Not right? Tell us

Asset Management Companylisted by Asset Management CompanyMenlo Park · $500K – $2M

How we know: Asset Management Company's portfolio page · Not right? Tell us

Canaan Partnerslisted by Canaan PartnersStamford · $500K – $20M

How we know: Canaan Partners's portfolio page · a partner's Signal profile · open dataset · 5k.vc investor directory · Not right? Tell us

Frazier Life Scienceslisted by Frazier Life SciencesPalo Alto

How we know: Frazier Life Sciences's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us

Pappas Capitallisted by Pappas CapitalDurham

How we know: Pappas Capital's portfolio page · Not right? Tell us

Sanderling Ventureslisted by Sanderling VenturesSan Mateo · $50K – $1M

How we know: Sanderling Ventures's portfolio page · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$34.9M disclosed across 1 round · 2019

▶$34.9MraisedJul 2019 · 1 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Mike ShermanExecutive Officer, Director
  • Ronald C. Renaud, JrDirector
  • W. Garrett NicholsExecutive Officer
  • Michael A. AlrutzExecutive Officer
  • Randall LanierExecutive Officer
  • Roy W. WareExecutive Officer
  • Heather Knight-TrentExecutive Officer
  • Odin NadererExecutive Officer
  • Martha J. DemskiDirector
  • James M. DalyDirector
  • Catherine L. GillissDirector
  • Edward F. Greissing, Jr.Director
  • Patrick MachadoDirector
  • Robert J. MeyerDirector
  • Fred A. MiddletonDirector
  • Mike AndrioleExecutive Officer
Offering amount
$34.9M
Amount sold
$34.9M
First sale
Jul 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Chimerix do?
Chimerix is a biopharmaceutical company developing therapies for rare diseases and cancers, with a focus on advancing treatments through biomarker-driven approaches and precision medicine.
Who are Chimerix's investors?
Chimerix's investors include Aisling Capital, Alta Partners, Asset Management Company, Canaan Partners, Frazier Life Sciences, Pappas Capital, Sanderling Ventures.
How much funding has Chimerix raised?
Chimerix has disclosed $34.9M raised across 1 round.
Where is Chimerix headquartered?
Chimerix is headquartered in Durham, US.